Brainsway's Deep TMS device gets FDA OK for depression treatment

01/10/2013 | Globes (Israel)

The FDA has cleared Brainsway's Deep TMS device for use in treating patients with depression who don't respond to drugs during an episode. The clearance paves the way for Brainsway to enter a key market in the U.S., which the firm says is worth billions of dollars per year.

View Full Article in:

Globes (Israel)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ